TD Cowen raised the firm’s price target on Bio-Techne (TECH) to $80 from $70 and keeps a Buy rating on the shares. The firm updated its model following its Q2 results and organic beat.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TECH:
- Bio-Techne price target raised to $79 from $70 at UBS
- Bio-Techne price target raised to $70 from $61 at Baird
- Bio-Techne Earnings Call Balances Headwinds With Margin Gains
- Bio-Techne: Near-Term Resilience and Margin Expansion Support Accelerating Growth and Buy Rating Into 2027
- Bio-Techne price target raised to $80 from $70 at Citi